Zortress

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 0078-0415
  • Package NDC 0078-0415-20
  • Application number NDA021560
  • SPL ID ade28559-5fac-4dfd-a56c-c453ceb9e30b
  • SPL set ID e082a024-7850-400b-a5c2-2a140612562a
  • UNII 9HW64Q8G6G
  • RxCUI 977427
  • RxCUI 977431
  • RxCUI 977434
  • RxCUI 977436
  • RxCUI 977438
  • RxCUI 977440
  • RxCUI 2056895
  • RxCUI 2056897

What the source publishes

Labeler
Novartis Pharmaceuticals Corporation
Active ingredients
everolimus
Form
TABLET
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:0078-0415_ade28559-5fac-4dfd-a56c-c453ceb9e30b
{
  "name": "Zortress",
  "splId": "ade28559-5fac-4dfd-a56c-c453ceb9e30b",
  "labels": [
    {
      "setId": "e082a024-7850-400b-a5c2-2a140612562a",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e082a024-7850-400b-a5c2-2a140612562a",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e082a024-7850-400b-a5c2-2a140612562a"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Novartis Pharmaceuticals Corporation",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "60 BLISTER PACK in 1 BOX (0078-0415-20)  / 1 TABLET in 1 BLISTER PACK (0078-0415-61)",
      "package_ndc": "0078-0415-20",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20100422"
    }
  ],
  "productId": "0078-0415_ade28559-5fac-4dfd-a56c-c453ceb9e30b",
  "useDomain": "unknown",
  "dosageForm": "TABLET",
  "productNdc": "0078-0415",
  "deaSchedule": null,
  "genericName": "everolimus",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "EVEROLIMUS",
      "strength": ".75 mg/1"
    }
  ],
  "applicationNumber": "NDA021560",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20100422",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175605",
      "N0000175076",
      "N0000182141",
      "N0000182137",
      "N0000175625",
      "N0000175624",
      "N0000175550"
    ],
    "unii": [
      "9HW64Q8G6G"
    ],
    "rxcui": [
      "977427",
      "977431",
      "977434",
      "977436",
      "977438",
      "977440",
      "2056895",
      "2056897"
    ],
    "spl_set_id": [
      "e082a024-7850-400b-a5c2-2a140612562a"
    ],
    "pharm_class_pe": [
      "Decreased Immunologic Activity [PE]"
    ],
    "pharm_class_epc": [
      "Kinase Inhibitor [EPC]",
      "mTOR Inhibitor Immunosuppressant [EPC]"
    ],
    "pharm_class_moa": [
      "Protein Kinase Inhibitors [MoA]",
      "Cytochrome P450 3A4 Inhibitors [MoA]",
      "Cytochrome P450 2D6 Inhibitors [MoA]",
      "mTOR Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "Novartis Pharmaceuticals Corporation"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:0078-0415_ade28559-5fac-4dfd-a56c-c453ceb9e30b"